| View |
|
DRP-120107
|
Lidocaine (as Hydrochloride) + Epinephrine
|
Xylodent
|
20 mg/10 mcg per mL (36 mg/18 mcg per 1.8 mL)
|
|
Local Anesthetic
|
Harmann Pharmaceutical Labs. (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
04 August 2024
|
22 August 2029
|
| View |
|
DRP-12117
|
Trimetazidine Dihydrochloride
|
Trivasc
|
35mg
|
Modified-Release Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
14 June 2022
|
07 December 2026
|
| View |
|
DRP-11680-02
|
Thiamine Hydrochloride (Vitamin B1) + Pyridoxine Hydrochloride ( Vitamin B6) + Cyanocobalamin ( Vitamin B12)
|
Nerviseth
|
100 mg/ 5 mg/ 50 mcg
|
Capsule
|
VITAMIN
|
Eurasia Research Pharma Corporation
|
Philippines
|
-
|
14 June 2022
|
18 June 2025
|
| View |
|
DRP-10929-07
|
Norepinephrine (as bitartrate)
|
Norpho
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Makcur Laboratories Limited
|
India
|
-
|
14 June 2022
|
31 January 2027
|
| View |
|
DRP-10892-01
|
Zoledronic Acid (As Monohydrate)
|
Zolev
|
800 mcg/mL (4 mg/5 mL)
|
Concentrated Solution for Injection (IV Infusion)
|
BISPHOSPHONATE
|
Aroma Ilac San. Ltd. Sti
|
Turkey
|
-
|
14 June 2022
|
14 December 2026
|
| View |
|
DRP-10021-03
|
Multivitamins
|
Bonvits
|
(See reverse for Formulation)
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
14 June 2022
|
09 July 2026
|
| View |
|
DRP-8931-01
|
Carboplatin
|
Carboxel-150
|
10 mg/mL ( 150 mg/15mL )
|
Solution for Injection ( IV Infusion )
|
Antineoplastic
|
Intas Pharmaceuticals Limited
|
India
|
-
|
14 June 2022
|
29 July 2025
|
| View |
|
HRP-178-02
|
Carbocisteine
|
Flemsol
|
50 mg/mL
|
Syrup (Oral Drops)
|
Mucolytic
|
Diamond Laboratories Inc
|
Philippines
|
-
|
15 June 2022
|
08 February 2027
|
| View |
|
DRP-12122
|
Esomeprazole (as magnesium trihydrate)
|
Esoric 40
|
40mg
|
Enteric Coated Tablet
|
-
|
Mepro Pharmaceuticals Private Ltd
|
India
|
-
|
17 June 2022
|
22 December 2026
|
| View |
|
DRP-12124
|
Esomeprazole (as magnesium trihydrate)
|
Esoric-20
|
20mg
|
Enteric-Coated Tablet
|
-
|
Mepro Pharmaceuticals Private Ltd
|
India
|
-
|
17 June 2022
|
22 December 2026
|
| View |
DRP-12128_PI_01.pdf
|
DRP-12128
|
Olmesartan medoxomil + Amlodipine (as besilate)
|
Olmestal-A-25
|
20 mg/ 5 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
17 June 2022
|
29 June 2025
|
| View |
DRP-12129_PI_01.pdf
|
DRP-12129
|
Meropenem (as trihydrate)
|
BDMERO 500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
BDR Pharmaceuticals International Pvt. Ltd.
|
India
|
Renewal
|
12 February 2024
|
15 December 2029
|
| View |
|
DRP-12130
|
Lisinopril
|
Lisnoxl-10
|
10 mg
|
Tablet
|
Angiotensin-Converting Enzyme (ACE) Inhibitor
|
XL Laboratories Pvt. Ltd
|
India
|
Renewal
|
25 July 2024
|
06 January 2030
|
| View |
|
DRP-8637-11
|
Butamirate citrate
|
MD-Mirate
|
50 mg
|
Sustained-Release Tablet
|
Antitussives
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
-
|
17 June 2022
|
20 January 2025
|
| View |
|
DRP-660-02
|
Mefenamic Acid
|
Dolsten
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Interchemex Laboratories, Inc.
|
Philippines
|
-
|
17 June 2022
|
06 May 2027
|
| View |
DRP-121237_PI_01.pdf
|
DRP-121237
|
Gefitinib
|
Bdgef
|
250 mg
|
Film-Coated Tablet
|
Antineoplastic (Protein Kinase Inhibitor)
|
BDR Pharmaceuticals International Pvt. Ltd.
|
India
|
Renewal
|
25 August 2024
|
28 August 2030
|
| View |
|
DRP-11632-01
|
Levodropropizine
|
Extusiv
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 June 2022
|
22 October 2026
|
| View |
|
DRP-11090-01
|
Febuxostat
|
Febustin
|
80 mg
|
Film-Coated Tablet
|
Antihyperuricemic
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
-
|
20 June 2022
|
01 June 2026
|
| View |
|
DRP-11052-02
|
Febuxostat
|
Febuxtat
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Acme Formulation Pvt. Ltd.
|
India
|
-
|
20 June 2022
|
19 January 2027
|
| View |
|
DRP-10943-02
|
Sitagliptin (as hydrochloride) + Metformin Hydrochloride
|
Amaziptin-M 1000
|
50 mg/1 g
|
Film-Coated Tablet
|
Antidiabetic
|
Hetero Labs Limited (Unit-V, Block-VB)
|
India
|
-
|
20 June 2022
|
21 December 2026
|